NGT’s Crystallization and Solid-State Subject Matter Expert, Dr. Robert Dennehy, is one of three recent appointments to the Strategic Advisory Board at CatSci.
“Dr. Robert Dennehy is a consultant in pharmaceutical solid state and crystallization, with 27 years of industry experience gained at GSK. This experience – the latter of which was at a Senior Director level – covers all stages of development, from pre-phase I solid state selection through to QbD regulatory filing. In addition, Robert has led the technical development of major assets to market and will support CatSci through his expertise in pre-formulation and pharmaceutical development.”
Dr. Dennehy said: “I am really excited at the prospect of growing the materials sciences capability at CatSci. I believe that good science and sound methodology are key to making the best decisions in developing a drug. The culture at CatSci is dynamic and innovative; together with my industry experience, our partnership will be a winning combination!”
For more information on Robert’s expertise, or to get in touch regarding your drug development project, contact us here.